Vantage Financial Partners Ltd., Inc. Johnson & Johnson Transaction History

Vantage Financial Partners Ltd., Inc.

$374 Million
Q1 2024

A detailed history of Vantage Financial Partners Ltd., Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Vantage Financial Partners Ltd., Inc. holds 12,230 shares of JNJ stock, worth $1.79 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

12,230

Previous 13,055 6.32%

Holding current value

$1.79 Million

Previous $2.05 Million 5.47%

% of portfolio

0.52%

Previous 0.63%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $128,056 - $134,260	-825 Reduced 6.32%	12,230 $1.93 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $149,240 - $162,852	-1,025 Reduced 7.28%	13,055 $2.05 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $249,200 - $279,168	-1,600 Reduced 10.2%	14,080 $2.19 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $11,576 - $12,458	-75 Reduced 0.48%	15,680 $2.6 Million
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $37,762 - $45,065	250 Added 1.61%	15,755 $2.44 Million

Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $44,055 - $49,442	275 Added 1.81%	15,505 $2.74 Million
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $8,066 - $8,976	-50 Reduced 0.33%	15,230 $2.49 Million
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $96,709 - $106,955	575 Added 3.91%	15,280 $2.71 Million
Q1 2022 May 02, 2022	BUY	$158.14 - $179.59 $31,627 - $35,918	200 Added 1.38%	14,705 $2.61 Million
Q4 2021 Jan 27, 2022	BUY	$155.93 - $173.01 $54,575 - $60,553	350 Added 2.47%	14,505 $2.48 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $12,112 - $13,460	75 Added 0.53%	14,155 $2.29 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $207,324 - $222,391	1,300 Added 10.17%	14,080 $2.32 Million
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $15,307 - $17,048	100 Added 0.79%	12,780 $2.1 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $20,566 - $23,607	150 Added 1.2%	12,680 $2 Million
Q2 2020 Aug 07, 2020	SELL	$128.81 - $155.51 $34,778 - $41,987	-270 Reduced 2.11%	12,530 $1.76 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $55,570 - $76,995	500 Added 4.07%	12,800 $1.68 Million
Q4 2019 Jan 27, 2020	BUY	$127.5 - $146.44 $19,125 - $21,966	150 Added 1.23%	12,300 $1.79 Million
Q3 2019 Nov 07, 2019	BUY	$126.95 - $142.14 $19,042 - $21,320	150 Added 1.25%	12,150 $1.57 Million
Q2 2019 Aug 08, 2019	SELL	$131.15 - $144.24 $59,017 - $64,908	-450 Reduced 3.61%	12,000 $0
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $221,112 - $266,112	1,800 Added 16.9%	12,450 $1.61 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $405,960 - $447,983	3,400 Added 46.9%	10,650 $1.29 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $906,975 - $1.07 Million	7,250 New	7,250 $929,000

Others Institutions Holding JNJ

# of Institutions

4,148

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.

Account

Vantage Financial Partners Ltd., Inc. Johnson & Johnson Transaction History